S
Sumitomo Dainippon Pharma
Sumitomo Dainippon Pharma advances AI-designed OCD drug DSP-1181 to clinical trial in 12 months
Pharmaceutical & Life ScienceDrug Discovery & DevelopmentMachine Learning & Predictive Analytics
- Reported result:
- 12 months (vs. ~5 years) Discovery to Clinical Trial
- Deployment timeframe:
- Not reported by source
- Technology:
- Machine Learning & Predictive Analytics
- Vendor:
- Not available in record